Reviva Pharmaceuticals (RVPH) Institutional Ownership $0.46 0.00 (-0.11%) Closing price 04:00 PM EasternExtended Trading$0.46 +0.00 (+0.37%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Reviva Pharmaceuticals (NASDAQ:RVPH)CurrentInstitutional OwnershipPercentage63.18%Number ofInstitutional Buyers(last 12 months)15TotalInstitutional Inflows(last 12 months)$2.68MNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.06M Get RVPH Insider Trade Alerts Want to know when executives and insiders are buying or selling Reviva Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data RVPH Institutional Buying and Selling by Quarter Reviva Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 683 Capital Management LLC1,000,000$381K0.0%N/A2.083% 8/14/2025 Armistice Capital LLC2,692,000$1.03M0.0%N/A5.608% 8/12/2025 XTX Topco Ltd81,960$31K0.0%N/A0.171% 8/11/2025 Persistent Asset Partners Ltd641,174$244K0.2%+300.0%1.336% 8/8/2025 Geode Capital Management LLC448,202$171K0.0%+6.9%0.934% 5/16/2025 NewEdge Advisors LLC60,900$58K0.0%N/A0.130% 5/5/2025 Private Advisor Group LLC200,000$191K0.0%N/A0.428% 5/2/2025BluePointe Capital Management LLC47,185$45K0.0%+354.7%0.101% 2/17/2025 Tang Capital Management LLC170,000$308K0.0%N/A0.508% 2/17/2025 Millennium Management LLC1,804,488$3.27M0.0%-1.5%5.396% Get the Latest News and Ratings for RVPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Reviva Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 2/17/2025 Focus Partners Wealth60,000$109K0.0%-62.7%0.179% 2/17/2025 Cornerstone Select Advisors LLC17,500$32K0.0%N/A0.052% 2/17/2025 Ameriprise Financial Inc.46,467$84K0.0%N/A0.139% 2/14/2025 Schonfeld Strategic Advisors LLC1,058,100$1.92M0.0%-30.2%3.164% 2/14/2025 Tower Research Capital LLC TRC26,775$48K0.0%+848.8%0.080% 2/13/2025 XTX Topco Ltd25,020$45K0.0%N/A0.075% 2/13/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 2/12/2025 Geode Capital Management LLC311,701$564K0.0%+11.9%0.932% 2/6/2025 Raymond James Financial Inc.14,000$25K0.0%N/A0.042% 1/23/2025 EMC Capital Management44,535$81K0.0%+142.0%0.133% 1/22/2025 Drive Wealth Management LLC20,000$36K0.0%N/A0.060% 11/16/2024 Geode Capital Management LLC278,496$401K0.0%+17.9%0.833% 5/10/2024 Vanguard Group Inc.1,001,836$3.79M0.0%+2.8%3.588% 2/13/2024 Armistice Capital LLC1,764,000$9.09M0.1%+194.0%6.318% 1/30/2024 Vontobel Holding Ltd.14,000$72K0.0%N/A0.062% 11/15/2023 Armistice Capital LLC600,000$2.93M0.0%-27.2%2.649% 11/9/2023 EMC Capital Management123,915$613K0.4%+1,294.3%0.547% 8/7/2023 Wolverine Asset Management LLC14,501$85K0.0%+137.6%0.071% 7/27/2023 Virtu Financial LLC18,448$108K0.0%N/A0.090% 2/15/2023 Tang Capital Management LLC24,125$103K0.0%N/A0.118% 2/13/2023 EMC Capital Management123,915$527K0.5%+125.0%0.606% 2/1/2023 Wolverine Asset Management LLC6,814$29K0.0%+934.0%0.033% 11/7/2022 Virtu Financial LLC46,119$73K0.0%N/A0.226% 10/25/2022Raymond James & Associates33,000$52K0.0%+65.0%0.161% 2/10/2022 EMC Capital Management55,078$159K0.1%-27.4%0.364% 2/3/2022 Northwestern Mutual Wealth Management Co.9,299$27K0.0%N/A0.067% 11/9/2021BlackRock Inc.33,470$136K0.0%+82.7%0.241% 8/17/2021 Armistice Capital LLC714,700$3.47M0.1%N/A7.742% 8/13/2021 Renaissance Technologies LLC11,250$55K0.0%N/A0.122% 8/13/2021 Northern Trust Corp10,584$51K0.0%N/A0.115% Trump’s national nightmare is here (Ad)Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.Watch the National Emergency broadcast here8/13/2021 Geode Capital Management LLC67,724$329K0.0%N/A0.734% 8/13/2021 Vanguard Group Inc.529,464$2.57M0.0%N/A5.735% 5/18/2021 Millennium Management LLC35,310$203K0.0%N/A0.382% (Data available from 1/1/2016 forward) RVPH Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RVPH shares? During the previous two years, 20 institutional investors and hedge funds held shares of Reviva Pharmaceuticals. The most heavily invested institutionals were Vanguard Group Inc. ($3.79M), Millennium Management LLC ($3.27M), Schonfeld Strategic Advisors LLC ($1.92M), Armistice Capital LLC ($1.03M), 683 Capital Management LLC ($381K), Tang Capital Management LLC ($308K), and Persistent Asset Partners Ltd ($244K).Learn more on Reviva Pharmaceuticals' institutional investors. What percentage of Reviva Pharmaceuticals' stock is owned by institutional investors? 63.18% of Reviva Pharmaceuticals' stock is owned by institutional investors. Learn more on RVPH's institutional investor holdings. Which institutional investors have been buying Reviva Pharmaceuticals' stock? Of the 17 institutional investors that purchased Reviva Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($3.86M), 683 Capital Management LLC ($1M), Persistent Asset Partners Ltd ($480.86K), Private Advisor Group LLC ($200K), Tang Capital Management LLC ($170K), EMC Capital Management ($141.16K), and XTX Topco Ltd ($106.98K). How much institutional buying is happening at Reviva Pharmaceuticals? Institutional investors have bought a total of 5,014,249 shares in the last 24 months. This purchase volume represents approximately $2.68M in transactions. Which of Reviva Pharmaceuticals' major shareholders have been selling company stock? The following institutional investors have sold Reviva Pharmaceuticals stock in the last 24 months: Schonfeld Strategic Advisors LLC ($457.80K), Focus Partners Wealth ($101K), and Millennium Management LLC ($28.33K). How much institutional selling is happening at Reviva Pharmaceuticals? Institutional investors have sold a total of 587,126 shares in the last 24 months. This volume of shares sold represents approximately $1.06M in transactions. Related Companies MIST Major Shareholders ZNTL Major Shareholders BHST Major Shareholders CHRS Major Shareholders GNLX Major Shareholders FBRX Major Shareholders ALTS Major Shareholders CTOR Major Shareholders FATE Major Shareholders SCLX Major Shareholders This page (NASDAQ:RVPH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Reviva Pharmaceuticals Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Reviva Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access